377 related articles for article (PubMed ID: 25619822)
1. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent.
Yousuf M; Mukherjee D; Dey S; Chatterjee S; Pal A; Sarkar B; Pal C; Adhikari S
Bioorg Med Chem Lett; 2018 Apr; 28(6):1056-1062. PubMed ID: 29478704
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Upadhyay A; Chandrakar P; Gupta S; Parmar N; Singh SK; Rashid M; Kushwaha P; Wahajuddin M; Sashidhara KV; Kar S
J Med Chem; 2019 Jun; 62(11):5655-5671. PubMed ID: 31124675
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
8. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Trypanothione Reductase of Tissue-Residing
Mukherjee D; Yousuf M; Dey S; Chakraborty S; Chaudhuri A; Kumar V; Sarkar B; Nath S; Hussain A; Dutta A; Mishra T; Roy BG; Singh S; Chakraborty S; Adhikari S; Pal C
J Med Chem; 2020 Dec; 63(24):15621-15638. PubMed ID: 33296601
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of Methyl 4-(7-Hydroxy-4,4,8-Trimethyl-3-Oxabicyclo[3.3.1]Nonan-2-yl)Benzoate as an Antileishmanial Agent and Its Synergistic Effect with Miltefosine.
Bhalla P; Sultana S; Chiranjivi AK; Saikia AK; Dubey VK
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133553
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
12. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
[TBL] [Abstract][Full Text] [Related]
13. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
[TBL] [Abstract][Full Text] [Related]
14. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
15. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
[TBL] [Abstract][Full Text] [Related]
16. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
Zhu X; Farahat AA; Mattamana M; Joice A; Pandharkar T; Holt E; Banerjee M; Gragg JL; Hu L; Kumar A; Yang S; Wang MZ; Boykin DW; Werbovetz KA
Bioorg Med Chem Lett; 2016 May; 26(10):2551-2556. PubMed ID: 27048943
[TBL] [Abstract][Full Text] [Related]
19. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
[TBL] [Abstract][Full Text] [Related]
20. β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
Chandrakar P; Gunaganti N; Parmar N; Kumar A; Singh SK; Rashid M; Wahajuddin M; Mitra K; Narender T; Kar S
Eur J Med Chem; 2019 Nov; 182():111632. PubMed ID: 31499363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
